Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial
Subcutaneous is the Standard: For research applications around a bony and tendon-heavy joint like the ankle, subcutaneous (Sub-Q) injection is overwhelmingly the preferred method
Our Vitamin B12 therapy is dispensed by a nurse practitioner, making it safe and effective
A confirmatory dose-ranging study of riluzole in ALS
A 2025 pilot study tested IV BPC-157 up to 20 mg in 2 healthy adults for safety only, finding it well tolerated but conducting no efficacy testing
US$ 27.56
US$ 23.40
US$ 23.41
US$ 27.89
US$ 21.11
US$ 24.51
US$ 23.17
US$ 21.94
US$ 20.70
